首页 | 本学科首页   官方微博 | 高级检索  
     


Re: Preliminary Results for Avelumab Plus Axitinib as First-Line Therapy in Patients with Advanced Clear-cell Renal-cell Carcinoma (JAVELIN Renal 100): An Open-label,Dose-finding and Dose-expansion,Phase 1b Trial
Authors:Viktor Grünwald  Boris Hadaschik
Affiliation:1. Interdisciplinary Genitourinary Oncology, West-German Cancer Center, University Hospital Essen, Essen, Germany;2. Department of Urology, University Hospital Essen, Essen, Germany
Abstract:
Keywords:Corresponding author. Interdisciplinary Genitourinary Oncology   West-German Cancer Center   University Hospital Essen   Hufelandstrasse 55   45147 Essen   Germany.
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号